1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Addictions Therapeutics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Addictions Therapeutics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Addictions Therapeutics Market Regional Analysis
6.2 Asia Pacific Addictions Therapeutics Market Revenue 2017-2027 (US$ Million)
6.3 Asia Pacific Addictions Therapeutics Market Forecast Analysis
7. Asia Pacific Addictions Therapeutics Market Analysis – by Treatment Type
7.1 Nicotine Addiction Treatment
- 7.1.1 Overview
- 7.1.2 Nicotine Addiction Treatment: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Alcohol Addiction Treatment
- 7.2.1 Overview
- 7.2.2 Alcohol Addiction Treatment: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Opioid Addiction Treatment
- 7.3.1 Overview
- 7.3.2 Opioid Addiction Treatment: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Other Substance Addiction Treatment
- 7.4.1 Overview
- 7.4.2 Other Substance Addiction Treatment: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. Asia Pacific Addictions Therapeutics Market Analysis – by Drug Type
8.1 Varenicline
- 8.1.1 Overview
- 8.1.2 Varenicline: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Bupropion
- 8.2.1 Overview
- 8.2.2 Bupropion: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Nicotine Replacement Products
- 8.3.1 Overview
- 8.3.2 Nicotine Replacement Products: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Buprenorphine
- 8.4.1 Overview
- 8.4.2 Buprenorphine: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.5 Naltrexone
- 8.5.1 Overview
- 8.5.2 Naltrexone: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.6 Disulfiram
- 8.6.1 Overview
- 8.6.2 Disulfiram: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. Asia Pacific Addictions Therapeutics Market Analysis – by Treatment Center
9.1 Outpatient Treatment Center
- 9.1.1 Overview
- 9.1.2 Outpatient Treatment Center: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Residential Treatment Center
- 9.2.1 Overview
- 9.2.2 Residential Treatment Center: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Inpatient Treatment Center
- 9.3.1 Overview
- 9.3.2 Inpatient Treatment Center: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. Asia Pacific Addictions Therapeutics Market Analysis – by Distribution Channel
10.1 Hospitals
- 10.1.1 Overview
- 10.1.2 Hospitals: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)
10.2 Medical Stores
- 10.2.1 Overview
- 10.2.2 Medical Stores: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)
11. Asia Pacific Addictions Therapeutics Market – Asia-Pacific Analysis
11.1 Overview
11.2 Asia-Pacific
- 11.2.1 Asia Pacific Addictions Therapeutics Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 11.2.1.1 Asia Pacific Addictions Therapeutics Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 China:
Asia Pacific Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.1.1 China: Asia Pacific Addictions Therapeutics Market Breakdown, by Treatment Type
- 11.2.1.1.2 China: Asia Pacific Addictions Therapeutics Market Breakdown, by Drug Type
- 11.2.1.1.3 China: Asia Pacific Addictions Therapeutics Market Breakdown, by Treatment Center
- 11.2.1.1.4 China: Asia Pacific Addictions Therapeutics Market Breakdown, by Distribution Channel
- 11.2.1.2 India:
Asia Pacific Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.2.1 India: Asia Pacific Addictions Therapeutics Market Breakdown, by Treatment Type
- 11.2.1.2.2 India: Asia Pacific Addictions Therapeutics Market Breakdown, by Drug Type
- 11.2.1.2.3 India: Asia Pacific Addictions Therapeutics Market Breakdown, by Treatment Center
- 11.2.1.2.4 India: Asia Pacific Addictions Therapeutics Market Breakdown, by Distribution Channel
- 11.2.1.3 Japan:
Asia Pacific Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.3.1 Japan: Asia Pacific Addictions Therapeutics Market Breakdown, by Treatment Type
- 11.2.1.3.2 Japan: Asia Pacific Addictions Therapeutics Market Breakdown, by Drug Type
- 11.2.1.3.3 Japan: Asia Pacific Addictions Therapeutics Market Breakdown, by Treatment Center
- 11.2.1.3.4 Japan: Asia Pacific Addictions Therapeutics Market Breakdown, by Distribution Channel
- 11.2.1.4 Australia:
Asia Pacific Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.4.1 Australia: Asia Pacific Addictions Therapeutics Market Breakdown, by Treatment Type
- 11.2.1.4.2 Australia: Asia Pacific Addictions Therapeutics Market Breakdown, by Drug Type
- 11.2.1.4.3 Australia: Asia Pacific Addictions Therapeutics Market Breakdown, by Treatment Center
- 11.2.1.4.4 Australia: Asia Pacific Addictions Therapeutics Market Breakdown, by Distribution Channel
- 11.2.1.5 Rest of Asia-Pacific :
Asia Pacific Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Addictions Therapeutics Market Breakdown, by Treatment Type
- 11.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Addictions Therapeutics Market Breakdown, by Drug Type
- 11.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Addictions Therapeutics Market Breakdown, by Treatment Center
- 11.2.1.5.4 Rest of Asia-Pacific : Asia Pacific Addictions Therapeutics Market Breakdown, by Distribution Channel
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Indivior PLC
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 GlaxoSmithKline plc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Bausch Health Companies Inc
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Cipla Inc.
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Alvogen
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Camurus AB
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Hikma Pharmaceuticals PLC
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Get Free Sample For Asia Pacific Addictions Therapeutics Market
